InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Spaventa Andrew, Chief Executive Officer. Director active across 1 companies, notably Singular Genomics Systems, Inc.. In total, 5 reports have been logged. Regulator: SEC (Form 4). All data is free.
Declarations5 total
173,144 shares
Common Stock
SEC:0001209191-22-021034:0·
715,884 shares
Common Stock
SEC:0001209191-21-068185·
715,884 shares
Common Stock
SEC:0001209191-21-068185:0·
715,884 shares
Common Stock
SEC:0001209191-21-037022·
715,884 shares
Common Stock
SEC:0001209191-21-037022:0·
5 of 5 declarations
About Spaventa Andrew
Andrew Spaventa is the Chief Executive Officer of Singular Genomics Systems, Inc. In this role, he oversees the company's operations and is responsible for implementing the business strategy. Andrew brings significant expertise in the biotechnology sector, contributing to innovation and growth within the company. His leadership is essential for guiding Singular Genomics to new heights.
